Alpha-1 AD Carriers and Lung Cancer Risk

Overview

Información sobre este estudio

The purpose of this study is to collect medical and family histories, blood and/or tumor tissue samples from patients who are being tested for or who have or had lung cancer. This study will help us to develop better ways to screen people at risk for lung cancer and develop better treatments for patients diagnosed with lung cancer. This study will also help us to learn whether certain genes (inherited factors from your parents) increase the risk of developing lung cancer.

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • All primary lung cancer cases diagnosed between 2005 and 2009 who are ≥ 50 years of age and smoked cumulatively 20 pack-years or more of cigarettes
  • If a former smoker, stopped smoking within 10 years prior to diagnosis 
  • All Olmsted County residents diagnosed with primary lung cancer during 1997-2009 (approximately 400) will be included to continue our special emphasis of population-based analyses.  (Note: 200 cases may overlap between the two groups.)

Exclusion Criteria:

  • Patients who do not speak English 
  • From outside of Midwest region (MN, WI, IA, ND, SD, NE, KS, MO, IL, MI, IN, and OH) 
  • Are non-U.S. citizens or residents

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Ping Yang, M.D., Ph.D.

Cerrado para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publicaciones

Publications are currently not available
.
CLS-20313600

Mayo Clinic Footer